Literature DB >> 12038926

Publishing protocols of systematic reviews: comparing what was done to what was planned.

Chris A Silagy1, Philippa Middleton, Sally Hopewell.   

Abstract

CONTEXT: Publication of research protocols minimizes bias by explicitly stating a priori hypotheses and methods without prior knowledge of results.
METHODS: We conducted a retrospective comparative study to assess the extent to which the content of published Cochrane reviews had changed compared with their previously published protocols and to assess any potential impact these changes may have had in introducing bias to the study. We identified previously published protocols for new Cochrane reviews appearing in The Cochrane Library; 2000, issue 3. The texts of published protocols and completed reviews were compared. Two raters independently identified changes to the different sections of the protocol and classified the changes as none, minor, or major.
RESULTS: Of the 66 new Cochrane reviews, we identified a previously published protocol for 47 reviews. Of these, 43 reviews had at least 1 section that had undergone a major change compared with the most recently published protocol. The greatest variation between protocols and reviews was in the methods section, in which 68% of reviews (n = 32) had undergone a major change. Changes made in other sections that may have resulted in the introduction of bias included narrowing of objectives, addition of comparisons or new outcome measures, broadening of criteria for the types of study design included, and narrowing of types of participants included.
CONCLUSIONS: Research protocols, even if published, are likely to remain, at least to some extent, iterative documents. We found that a large number of changes were made to Cochrane reviews, some of which could be prone to influence by prior knowledge of results. Even if many of the changes between protocol and review improve the overall study, the reasons for making these should be clearly identified and documented within the final review.

Entities:  

Mesh:

Year:  2002        PMID: 12038926     DOI: 10.1001/jama.287.21.2831

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  58 in total

Review 1.  Considerations of traditional Chinese medicine as adjunct therapy in the management of ulcerative colitis.

Authors:  Chi Zhang; Miao Jiang; Aiping Lu
Journal:  Clin Rev Allergy Immunol       Date:  2013-06       Impact factor: 8.667

2.  Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group.

Authors:  Heloisa P Soares; Stephanie Daniels; Ambuj Kumar; Mike Clarke; Charles Scott; Suzanne Swann; Benjamin Djulbegovic
Journal:  BMJ       Date:  2004-01-03

Review 3.  Steps in the undertaking of a systematic review in orthopaedic surgery.

Authors:  Dario Sambunjak; Miljenko Franić
Journal:  Int Orthop       Date:  2011-12-24       Impact factor: 3.075

4.  Registering systematic reviews.

Authors:  Sharon Straus; David Moher
Journal:  CMAJ       Date:  2009-07-20       Impact factor: 8.262

Review 5.  Systematic reviews to ascertain the safety of diabetes medications.

Authors:  Michael R Gionfriddo; Oscar L Morey-Vargas; Juan P Brito; Aaron L Leppin; M Hassan Murad; Victor M Montori
Journal:  Curr Diab Rep       Date:  2014-04       Impact factor: 4.810

6.  Umbrella reviews: what they are and why we need them.

Authors:  Stefania Papatheodorou
Journal:  Eur J Epidemiol       Date:  2019-03-09       Impact factor: 8.082

7.  Bias due to changes in specified outcomes during the systematic review process.

Authors:  Jamie J Kirkham; Doug G Altman; Paula R Williamson
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

8.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  BMJ       Date:  2009-07-21

9.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  BMJ       Date:  2009-07-21

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.